Literature DB >> 18395015

Oxidative and nitrative protein modifications in Parkinson's disease.

Steven R Danielson1, Julie K Andersen.   

Abstract

Parkinson's disease (PD) is a complex neurodegenerative syndrome likely involving contributions from various factors in individuals including genetic susceptibility, exposure to environmental toxins, and the aging process itself. Increased oxidative stress appears to be a common causative aspect involved in the preferential loss of dopaminergic neurons in a region of the brain prominently affected by the disorder, the substantia nigra (SN). Loss of dopaminergic SN neurons is responsible for the classic clinical motor symptoms associated with PD. Several oxidative and nitrative posttranslational modifications (PTMs) have been identified on proteins pertinent to PD that may affect this or other aspects of disease progression. In this review, we discuss several examples of such PTMs to illustrate their potential consequences in terms of initiation or progression of PD neuropathophysiology.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18395015      PMCID: PMC2422863          DOI: 10.1016/j.freeradbiomed.2008.03.005

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  103 in total

1.  The A53T alpha-synuclein mutation increases iron-dependent aggregation and toxicity.

Authors:  N Ostrerova-Golts; L Petrucelli; J Hardy; J M Lee; M Farer; B Wolozin
Journal:  J Neurosci       Date:  2000-08-15       Impact factor: 6.167

2.  Effect of proteasome inhibition on cellular oxidative damage, antioxidant defences and nitric oxide production.

Authors:  M H Lee; D H Hyun; P Jenner; B Halliwell
Journal:  J Neurochem       Date:  2001-07       Impact factor: 5.372

3.  Dityrosine cross-linking promotes formation of stable alpha -synuclein polymers. Implication of nitrative and oxidative stress in the pathogenesis of neurodegenerative synucleinopathies.

Authors:  J M Souza; B I Giasson; Q Chen; V M Lee; H Ischiropoulos
Journal:  J Biol Chem       Date:  2000-06-16       Impact factor: 5.157

4.  Mass spectrometric quantification of 3-nitrotyrosine, ortho-tyrosine, and o,o'-dityrosine in brain tissue of 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-treated mice, a model of oxidative stress in Parkinson's disease.

Authors:  S Pennathur; V Jackson-Lewis; S Przedborski; J W Heinecke
Journal:  J Biol Chem       Date:  1999-12-03       Impact factor: 5.157

5.  Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease.

Authors:  G T Liberatore; V Jackson-Lewis; S Vukosavic; A S Mandir; M Vila; W G McAuliffe; V L Dawson; T M Dawson; S Przedborski
Journal:  Nat Med       Date:  1999-12       Impact factor: 53.440

6.  Oxidized forms of peroxiredoxins and DJ-1 on two-dimensional gels increased in response to sublethal levels of paraquat.

Authors:  A Mitsumoto; Y Nakagawa; A Takeuchi; K Okawa; A Iwamatsu; Y Takanezawa
Journal:  Free Radic Res       Date:  2001-09

7.  Glutathione depletion in PC12 results in selective inhibition of mitochondrial complex I activity. Implications for Parkinson's disease.

Authors:  N Jha; O Jurma; G Lalli; Y Liu; E H Pettus; J T Greenamyre; R M Liu; H J Forman; J K Andersen
Journal:  J Biol Chem       Date:  2000-08-25       Impact factor: 5.157

8.  Widespread nitration of pathological inclusions in neurodegenerative synucleinopathies.

Authors:  J E Duda; B I Giasson; Q Chen; T L Gur; H I Hurtig; M B Stern; S M Gollomp; H Ischiropoulos; V M Lee; J Q Trojanowski
Journal:  Am J Pathol       Date:  2000-11       Impact factor: 4.307

9.  Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions.

Authors:  B I Giasson; J E Duda; I V Murray; Q Chen; J M Souza; H I Hurtig; H Ischiropoulos; J Q Trojanowski; V M Lee
Journal:  Science       Date:  2000-11-03       Impact factor: 47.728

10.  Induction of alpha-synuclein aggregation by intracellular nitrative insult.

Authors:  E Paxinou; Q Chen; M Weisse; B I Giasson; E H Norris; S M Rueter; J Q Trojanowski; V M Lee; H Ischiropoulos
Journal:  J Neurosci       Date:  2001-10-15       Impact factor: 6.167

View more
  59 in total

1.  L-type calcium channel blockers and Parkinson disease in Denmark.

Authors:  Beate Ritz; Shannon L Rhodes; Lei Qian; Eva Schernhammer; Jørgen H Olsen; Søren Friis
Journal:  Ann Neurol       Date:  2010-05       Impact factor: 10.422

2.  Glutamoyl diester of the dietary polyphenol curcumin offers improved protection against peroxynitrite-mediated nitrosative stress and damage of brain mitochondria in vitro: implications for Parkinson's disease.

Authors:  Rajeswara Babu Mythri; G Harish; Shiv Kumar Dubey; Krishna Misra; M M Srinivas Bharath
Journal:  Mol Cell Biochem       Date:  2010-10-23       Impact factor: 3.396

3.  Mass spectrometry-based proteomics and peptidomics for biomarker discovery in neurodegenerative diseases.

Authors:  Xin Wei; Lingjun Li
Journal:  Int J Clin Exp Pathol       Date:  2008-06-20

Review 4.  Brain oxidative stress as basic target of antioxidant traditional oriental medicines.

Authors:  Tetsuya Konishi
Journal:  Neurochem Res       Date:  2008-11-06       Impact factor: 3.996

Review 5.  Neurotoxicity Linked to Dysfunctional Metal Ion Homeostasis and Xenobiotic Metal Exposure: Redox Signaling and Oxidative Stress.

Authors:  Carla Garza-Lombó; Yanahi Posadas; Liliana Quintanar; María E Gonsebatt; Rodrigo Franco
Journal:  Antioxid Redox Signal       Date:  2018-03-28       Impact factor: 8.401

Review 6.  Molecular strategies for targeting antioxidants to mitochondria: therapeutic implications.

Authors:  Nadezda Apostolova; Victor M Victor
Journal:  Antioxid Redox Signal       Date:  2015-03-10       Impact factor: 8.401

7.  Statin use and Parkinson's disease in Denmark.

Authors:  Beate Ritz; Angelika D Manthripragada; Lei Qian; Eva Schernhammer; Lene Wermuth; Jorgen Olsen; Soren Friis
Journal:  Mov Disord       Date:  2010-07-15       Impact factor: 10.338

Review 8.  Therapeutic targets for neuroprotection in acute ischemic stroke: lost in translation?

Authors:  Jeannette N Stankowski; Rishi Gupta
Journal:  Antioxid Redox Signal       Date:  2010-10-25       Impact factor: 8.401

Review 9.  Thiol-redox signaling, dopaminergic cell death, and Parkinson's disease.

Authors:  Aracely Garcia-Garcia; Laura Zavala-Flores; Humberto Rodriguez-Rocha; Rodrigo Franco
Journal:  Antioxid Redox Signal       Date:  2012-05-03       Impact factor: 8.401

10.  Antioxidant activity of growth hormone-releasing hormone antagonists in LNCaP human prostate cancer line.

Authors:  Nektarios Barabutis; Andrew V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.